Specifically, IL-1β appears to contribute to atrial fibrogenesis beyond the canonical inflammasome axis, highlighting the complexity of inflammatory signaling in hypertensive AF and the need for nuanced therapeutic approaches targeting both upstream and downstream inflammatory mediators. The gene discussed is IL1B; the disease is atrial fibrillation.